Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

LYFEGEN-Series-A-Fund

More Like This

PR Newswire associated0

Lyfegen Unveils Generative AI to Transform Drug Contracting and Accelerate Patient Access

PR Newswire associated0

Lyfegen and EVERSANA Collaborate to Revolutionize Drug Pricing and Access with AI-Driven Insights

ProductLife Group Acquires Stragen Services, Strengthening Pharmacovigilance and Clinical Safety Expertise Within the European Market

Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

Business Wire logo

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Liberis partners with Nexi to launch revenue-based financing into Germany

PR Newswire associated0

Synergi raises €2M to plug European homes and utilities into flexibility markets